How to buy NuCana stock

NuCana plc is a biotechnology business based in the US. NuCana shares (NCNA) are listed on the NASDAQ and all prices are listed in US Dollars. NuCana employs 29 staff and has a market cap (total outstanding shares value) of USD$246.3 million.

How to buy shares in NuCana

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for NuCana. Find the stock by name or ticker symbol: NCNA. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until NuCana reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of NuCana, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of NuCana. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Our top pick for

Beginners

Robinhood

Our top pick for

Building a portfolio

Sofi Invest

Our top pick for

Advanced investors

Webull

How we chose our top picks

We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs. We encourage you to compare stock platforms to find one that's best for your particular budget and goals.

• Our pick for beginners. We chose Robinhood for this category because it offers commission-free trading and is easy to use. You can search for stocks by company name, and the mobile app is clean and intuitive to use.
• Our pick for building a portfolio. We chose SoFi for this category because it offers both commission-free stocks and a free robo-advisor. That means you can open an active investing account to pick and choose companies you want to invest in, and open a robo-advisor account to help you build a portfolio and manage how much risk you take on.
• Our pick for active investors. We picked Webull for this category because its platform offers features that cater to advancing investors as well as beginners. The desktop app is outfitted with an extensive set of research tools, the mobile app gets high grades from users and traders can test strategies with a paper-trading feature.

What's in this guide?

1. NCNA shares summary
2. Compare share dealing platforms
3. Is NCNA stock a buy or sell?
4. Stock performance over time
5. Can I short NCNA shares?
6. NuCana's financials
7. How volatile are NCNA shares?
8. Does NuCana pay a dividend?
9. Other common questions

NuCana share price

Use our graph to track the performance of NCNA stocks over time.

NuCana shares at a glance

• Key figures

Information last updated 2021-03-03.

52-week range	USD$4.04 - USD$9.75
50-day moving average	USD$5.9832
200-day moving average	USD$5.2102
Wall St. target price	USD$1155.19
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-0.634

Buy NuCana shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Sort by:

Name	Product	Stock trade fee	Asset types	Option trade fee	Annual fee	Signup bonus
Robinhood		$0	Stocks, Options, ETFs, Gold/Commodities	$0	0%	Free stock (chosen randomly with a value anywhere between $2.50 and $200) Sign up using the "go to site" link	Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.	Go to site More Info		loading Fetching your data...
Webull		$0	Stocks, Options, ETFs	$0	0%	Get two free stock valued between $2.50 and $250 Open an account	Margin financing rates start at 3.99%. No monthly subscription fees for margin.	Go to site More Info		loading Fetching your data...
TradeStation		$0	Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency	$0 + $0.50/contract		$50 Deposit qualifying assets of $5,000+	A platform built for all kinds of traders and all styles of trading	Go to site More Info		loading Fetching your data...
Tastyworks		$0	Stocks, Options, Cryptocurrency	Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg Futures: $2.50/contract to open, $0 to close	0%	Get 100 shares of stock (worth $1 to $6 a share) Open and fund a new cash or margin account with $2,000+	Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.	Go to site More Info		loading Fetching your data...
Interactive Brokers		$0	Stocks, Bonds, Options	$0 + $0.65/contract, $1 minimum	0%	N/A	IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.	Go to site More Info		loading Fetching your data...

loading

Compare up to 4 providers

Clear selection

Compare

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy NuCana stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of NuCana plc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Shorting NuCana shares

There are currently 42,974 NuCana shares held short by investors – that's known as NuCana's "short interest". This figure is 57.7% down from 101,578 last month.

There are a few different ways that this level of interest in shorting NuCana shares can be evaluated.

NuCana's "short interest ratio" (SIR)

NuCana's "short interest ratio" (SIR) is the quantity of NuCana shares currently shorted divided by the average quantity of NuCana shares traded daily (recently around 1.1 million). NuCana's SIR currently stands at 0.04. In other words for every 100,000 NuCana shares traded daily on the market, roughly 40 shares are currently held short.

However NuCana's short interest can also be evaluated against the total number of NuCana shares, or, against the total number of tradable NuCana shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case NuCana's short interest could be expressed as 0% of the outstanding shares (for every 100,000 NuCana shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable NuCana shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against NuCana.

Find out more about how you can short NuCana stock.

NuCana share price volatility

Over the last 12 months, NuCana's shares have ranged in value from as little as $4.04 up to $9.75. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NuCana's is 0.8521. This would suggest that NuCana's shares are less volatile than average (for this exchange).

NuCana overview

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase Ib and Phase III clinical trials for the treatment of patients with biliary tract cancer; a Phase II clinical trial for the treatment of patients with platinum-resistant ovarian cancer; Phase Ib clinical trial for the treatment of patients with biliary cancer; and Phase III clinical trial for the treatment of patients with metastatic pancreatic cancer. The company is also developing NUC-3373, a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil, which is in Phase I clinical trial for the treatment of patients with advanced solid tumors; and NUC-7738, a nucleoside analog that is in Phase I clinical trial for the treatment of patients with advanced solid tumors and hematological tumors. NuCana plc has a research, collaboration, and license agreement with Cardiff University and University College Cardiff Consultants Ltd. for the design, synthesis, characterization, and evaluation of ProTides; and an assignment, license, and collaboration agreement with Cardiff ProTides Ltd. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017. NuCana plc was incorporated in 1997 and is headquartered in Edinburgh, the United Kingdom.

Frequently asked questions

• What percentage of NuCana is owned by insiders or institutions?

  Currently 0.415% of NuCana shares are held by insiders and 53.71% by institutions.

• How many people work for NuCana?

  Latest data suggests 29 work at NuCana.

• When does the fiscal year end for NuCana?

  NuCana's fiscal year ends in December.

• Where is NuCana based?

  NuCana's address is: 3 Lochside Way, Edinburgh, United Kingdom, EH12 9DT

• What is NuCana's ISIN number?

  NuCana's international securities identification number is: US67022C1062

• What is NuCana's CUSIP number?

  NuCana's Committee on Uniform Securities Identification Procedures number is: 67022C106